To further elucidate the regulatory effects of EQF on key targets in NAFLD, RT-qPCR and Western blot were used to assess the mRNA and protein expression levels of BCL2, CASP3, ESR1, JUN, MMP9, STAT3, and TNF. This evidence concerns the gene ESR1 and metabolic dysfunction-associated steatotic liver disease.